Imunon, Inc. (IMNN) › Capital ExpendituresImunon, Inc. (IMNN) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $6.7K2011: $573.4K2012: $613.4K2013: $57.5K2014: $672.3K2015: $109.3K2016: $62.5K2017: $38.6K2018: $138.4K2019: $349.2K2020: $19.1K2021: $311.6K2022: $267.8K2023: $451.8K2024: $29.5K2025: $280.6K$280.6K2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$280.6K+849.8%2024$29.5K-93.5%2023$451.8K+68.7%2022$267.8K-14.1%2021$311.6K+1532.2%2020$19.1K-94.5%2019$349.2K+152.3%2018$138.4K+258.3%2017$38.6K-38.2%2016$62.5K-42.8%2015$109.3K-83.7%2014$672.3K+1069.3%2013$57.5K-90.6%2012$613.4K+7.0%2011$573.4K+8401.2%2010$6.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share